Delta Global Management LP Purchases Shares of 4,567 Cencora, Inc. $COR

Delta Global Management LP acquired a new position in Cencora, Inc. (NYSE:COR) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,567 shares of the company’s stock, valued at approximately $1,435,000.

Other institutional investors have also recently made changes to their positions in the company. Kemnay Advisory Services Inc. purchased a new stake in Cencora during the fourth quarter worth $25,000. Oakworth Capital Inc. acquired a new stake in shares of Cencora during the 4th quarter valued at about $26,000. Elyxium Wealth LLC purchased a new stake in shares of Cencora in the fourth quarter valued at approximately $27,000. Archer Investment Corp increased its holdings in Cencora by 134.3% in the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. Finally, Motiv8 Investments LLC acquired a new stake in shares of Cencora in the fourth quarter valued at about $29,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Cencora Stock Performance

NYSE:COR opened at $309.67 on Monday. The company’s 50-day moving average price is $284.52 and its 200-day moving average price is $316.29. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The company has a market cap of $60.25 billion, a P/E ratio of 23.75, a P/E/G ratio of 1.72 and a beta of 0.58. Cencora, Inc. has a twelve month low of $244.82 and a twelve month high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same period in the prior year, the company posted $4.42 EPS. The firm’s revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, sell-side analysts forecast that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Friday, May 15th. Cencora’s payout ratio is currently 18.40%.

Cencora announced that its Board of Directors has initiated a stock buyback plan on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 3.9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s leadership believes its shares are undervalued.

Wall Street Analyst Weigh In

COR has been the subject of several research analyst reports. Citigroup reduced their price target on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Bank of America boosted their price objective on Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 24th. Morgan Stanley set a $342.00 target price on Cencora in a report on Friday, May 8th. Wells Fargo & Company decreased their target price on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research report on Monday, May 11th. Finally, Evercore set a $360.00 price target on Cencora in a research note on Wednesday, April 8th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Cencora has a consensus rating of “Moderate Buy” and a consensus target price of $367.75.

Insider Activity

In related news, Director Lauren M. Tyler purchased 550 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was acquired at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the transaction, the director directly owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.38% of the stock is owned by company insiders.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.